A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Strength and Safety in Adults With Autosomal Dominant RYR1-related Myopathy

Clinical trial NCT07560020 · RECRUITING

Trial details

NCT number: NCT07560020
Sponsor: RyCarma Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autosomal Dominant RYR1-Related Myopathy

Start date: 2026-07-01
Primary completion: 2027-08-27
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.